Skip to main content

Peer Review reports

From: Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study

Original Submission
11 Oct 2017 Submitted Original manuscript
22 Jan 2018 Author responded Author comments - Yoshihiko Tomita
Resubmission - Version 2
22 Jan 2018 Submitted Manuscript version 2
8 Oct 2018 Author responded Author comments - Yoshihiko Tomita
3 May 2018 Reviewed Reviewer Report - Giuseppe Procopio
30 May 2018 Reviewed Reviewer Report - Ian Davis
8 Sep 2018 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 3
8 Oct 2018 Submitted Manuscript version 3
11 Dec 2018 Author responded Author comments - Yoshihiko Tomita
11 Oct 2018 Reviewed Reviewer Report - Ian Davis
Resubmission - Version 4
11 Dec 2018 Submitted Manuscript version 4
Publishing
13 Dec 2018 Editorially accepted
7 Jan 2019 Article published 10.1186/s12885-018-5224-6

You can find further information about peer review here.

Back to article page